MEMPHASYS LIMITED. - Announcements

11.1%

0.4¢

Market Cap $7.934M

Technology Scientific & Technical Instruments

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive... Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.More

Corporate Spotlight

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.
View the full Corporate Spotlight

LATEST INTERVIEW

Announcements

Filter Results

All Price Sensitive Only

MEM	Rights Issue offer - Letter to ineligible shareholders		18/08/22	67.94KB	Share
MEM	Non-Renounceable Issue		18/08/22	539.03KB	Share
MEM	Update - Proposed issue of securities - MEM		18/08/22	37.52KB	Share
MEM	Proposed issue of securities - MEM		17/08/22	39.11KB	Share
MEM	Reinstatement to Official Quotation	PRICE SENSITIVE	17/08/22	85.54KB	Share
MEM	$3.36 capital raising to accelerate FELIX commercialisation	PRICE SENSITIVE	17/08/22	236.6KB	Share
MEM	Court Orders Granted and update on Proposed Capital Raising		11/08/22	266.15KB	Share
MEM	Cleansing Statement		02/08/22	155.82KB	Share
MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	1.72MB	Share
MEM	Suspension from Official Quotation	PRICE SENSITIVE	29/07/22	560.19KB	Share
MEM	Trading Halt	PRICE SENSITIVE	27/07/22	150.59KB	Share
MEM	Monash IVF clinical study enrols first patient using FELIX	PRICE SENSITIVE	28/06/22	256.47KB	Share
MEM	Notification of cessation of securities - MEM		27/06/22	21.71KB	Share
MEM	Felix System commercialisation update	PRICE SENSITIVE	09/06/22	205.41KB	Share
MEM	Notification of cessation of securities - MEM		06/06/22	21.63KB	Share
MEM	Response to ASX Query	PRICE SENSITIVE	17/05/22	219.33KB	Share
MEM	Final Director's Interest Notice SH		26/04/22	161.14KB	Share
MEM	Initial Director's Interest Notice - RC		26/04/22	132.08KB	Share
MEM	Non-Exec Chair Appointment and Director Resignation		26/04/22	168.15KB	Share
MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	12/04/22	309.52KB	Share
MEM	Follow up sales of FelixTM System	PRICE SENSITIVE	30/03/22	198.06KB	Share
MEM	SAMSON stallion fertility device returns positive results		22/03/22	209.49KB	Share
MEM	MEM Achieves ISO 13485 Compliance	PRICE SENSITIVE	14/03/22	168.73KB	Share
MEM	Presentation at Pitt St Research conference		03/03/22	2.27MB	Share
MEM	Appendix 4D and Half Year Report and Accounts	PRICE SENSITIVE	25/02/22	1.08MB	Share
MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	25/01/22	308.05KB	Share
MEM	Change of Director's Interest Notice		24/01/22	172.14KB	Share
MEM	Convertible Note sale		19/01/22	149.7KB	Share
MEM	First Felix System commercial sale for clinical IVF use	PRICE SENSITIVE	20/12/21	187.71KB	Share
MEM	Memphasys & Monash IVF commence clinical trial of FELIX		09/12/21	185.81KB	Share
MEM	SAMSON stallion fertility device used in field trials		02/12/21	201.6KB	Share
MEM	Change of Director's Interest Notice AC		26/11/21	199.43KB	Share
MEM	Results of Meeting		25/11/21	51.47KB	Share
MEM	First Sale of FelixTM in Research Application	PRICE SENSITIVE	22/11/21	229.74KB	Share
MEM	Verification and Validation Assessments Complete	PRICE SENSITIVE	03/11/21	222.28KB	Share
MEM	Notification of cessation of securities - MEM		25/10/21	21.73KB	Share
MEM	MEM receives $1.36m R&D tax rebate		25/10/21	169.2KB	Share
MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	21/10/21	343.4KB	Share
MEM	Notice of Annual General Meeting/Proxy Form		19/10/21	480.06KB	Share
MEM	Cleansing Notice - Section 708A(5)(e)		28/09/21	206.14KB	Share
MEM	Application for quotation of securities - MEM		28/09/21	24.93KB	Share
MEM	Acceleration of reproductive biotechnology portfolio		20/09/21	239.76KB	Share
MEM	Appendix 3G correction		17/09/21	424.63KB	Share
MEM	Notification regarding unquoted securities - MEM		14/09/21	27.81KB	Share
MEM	Change of Director's Interest Notice - AC and AG		10/09/21	202.32KB	Share
MEM	Appendix 3G		03/09/21	424.59KB	Share
MEM	Notification regarding unquoted securities - MEM		01/09/21	28.15KB	Share
MEM	MEM reaches settlement agreement with Hydrix	PRICE SENSITIVE	01/09/21	234.86KB	Share
MEM	HYD: Commercial arrangement between Hydrix and Memphasys	PRICE SENSITIVE	31/08/21	458.74KB	Share
MEM	FY21 Corporate Governance Statement and Appendix 4G		31/08/21	524.12KB	Share
MEM	FY21 Full Year Statutory Accounts		30/08/21	1.14MB	Share
MEM	Preliminary Final Report	PRICE SENSITIVE	30/08/21	904KB	Share
MEM	Results of General Meeting		24/08/21	194.76KB	Share
MEM	General Meeting to be held as a Virtual Meeting of members		20/08/21	219.43KB	Share
MEM	Disclosure Document - Cleansing Notice		30/07/21	206.28KB	Share
MEM	Application for quotation of securities - MEM		30/07/21	24.67KB	Share
MEM	Notification regarding unquoted securities - MEM		30/07/21	28.22KB	Share
MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/07/21	300.08KB	Share
MEM	Notice of General Meeting/Proxy Form		23/07/21	524.66KB	Share
MEM	Global andrology expert, Professor John Aitken, joins MEM		05/07/21	242.01KB	Share
MEM	Upgraded Felix Device verification passed		01/07/21	110.65KB	Share
MEM	Proposed issue of Securities - MEM		26/05/21	32.45KB	Share
MEM	Memphasys completes $3m capital raise	PRICE SENSITIVE	26/05/21	299.47KB	Share
MEM	Trading Halt	PRICE SENSITIVE	25/05/21	150.18KB	Share
MEM	Assisted reproductive biotechnology products update		04/05/21	274.49KB	Share
MEM	Prof. John Aitken receives distinguished andrology award		04/05/21	183.77KB	Share
MEM	Quarterly Cashflow Report	PRICE SENSITIVE	30/04/21	162.87KB	Share
MEM	Quarterly Activities Report	PRICE SENSITIVE	30/04/21	201.54KB	Share
MEM	Granted US patents strengthens IP portfolio		29/04/21	177.95KB	Share
MEM	Felix device - V&V progress and KOL study update		27/04/21	197.36KB	Share
MEM	FELIX device Verification and Validation process update		30/03/21	205.13KB	Share
MEM	Felix device validation testing delayed		08/03/21	180.11KB	Share
MEM	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	1.46MB	Share
MEM	Change of Director's Interest Notice - Coutts		17/02/21	139.62KB	Share
MEM	Cancellation of Performance Options		17/02/21	132.15KB	Share
MEM	Disclosure Document - s708A cleansing notice		02/02/21	206.11KB	Share
MEM	Appendix 2A option conversion		02/02/21	290.61KB	Share
MEM	Initial Felix product sales update	PRICE SENSITIVE	24/12/20	206.7KB	Share
MEM	Executive Chair contract renewal		01/12/20	171.51KB	Share
MEM	Results of Meeting		19/11/20	201.6KB	Share
MEM	Chairman's Address to Shareholders		19/11/20	250.74KB	Share
MEM	FELIX verification and validation update	PRICE SENSITIVE	19/11/20	295.59KB	Share
MEM	Reinstatement of Options		28/10/20	172.51KB	Share
MEM	Cleansing Statement		19/10/20	221.5KB	Share
MEM	Appendix 2A		19/10/20	290.03KB	Share
MEM	Notice of Annual General Meeting/Proxy Form		16/10/20	351.69KB	Share
MEM	FELIX commercialisation update		09/10/20	216.46KB	Share
MEM	MEM receives Good Design Award for Felix device		09/09/20	268.15KB	Share
MEM	R&D tax incentive scheme rebate received		09/09/20	136.78KB	Share
MEM	2020 Corporate Governance Statement		07/09/20	286.57KB	Share
MEM	2020 Appendix 4G		07/09/20	152.11KB	Share
MEM	Full Year Statutory Accounts		27/08/20	1.13MB	Share
MEM	Preliminary Final Report	PRICE SENSITIVE	27/08/20	1.03MB	Share
MEM	Disclosure Document - Cleansing Notice		19/08/20	220.79KB	Share
MEM	Appendix 2A		19/08/20	289.8KB	Share
MEM	MEM and Newcastle Uni prospective reproductive technologies		17/08/20	344.01KB	Share
MEM	Performance rights vest on first market entry into Canada		10/07/20	204.78KB	Share
MEM	Cancellation of options		06/07/20	152.38KB	Share
MEM	Securities Trading Policy		02/07/20	304.55KB	Share
MEM	MEM virtual presentation investor webinar		26/06/20	177.77KB	Share

MEM Rights Issue offer - Letter to ineligible shareholders
18/08/22		67.94KB	Share
MEM Non-Renounceable Issue
18/08/22		539.03KB	Share
MEM Update - Proposed issue of securities - MEM
18/08/22		37.52KB	Share
MEM Proposed issue of securities - MEM
17/08/22		39.11KB	Share
MEM Reinstatement to Official Quotation
17/08/22	PRICE SENSITIVE	85.54KB	Share
MEM $3.36 capital raising to accelerate FELIX commercialisation
17/08/22	PRICE SENSITIVE	236.6KB	Share
MEM Court Orders Granted and update on Proposed Capital Raising
11/08/22		266.15KB	Share
MEM Cleansing Statement
02/08/22		155.82KB	Share
MEM Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	1.72MB	Share
MEM Suspension from Official Quotation
29/07/22	PRICE SENSITIVE	560.19KB	Share
MEM Trading Halt
27/07/22	PRICE SENSITIVE	150.59KB	Share
MEM Monash IVF clinical study enrols first patient using FELIX
28/06/22	PRICE SENSITIVE	256.47KB	Share
MEM Notification of cessation of securities - MEM
27/06/22		21.71KB	Share
MEM Felix System commercialisation update
09/06/22	PRICE SENSITIVE	205.41KB	Share
MEM Notification of cessation of securities - MEM
06/06/22		21.63KB	Share
MEM Response to ASX Query
17/05/22	PRICE SENSITIVE	219.33KB	Share
MEM Final Director's Interest Notice SH
26/04/22		161.14KB	Share
MEM Initial Director's Interest Notice - RC
26/04/22		132.08KB	Share
MEM Non-Exec Chair Appointment and Director Resignation
26/04/22		168.15KB	Share
MEM Quarterly Activities/Appendix 4C Cash Flow Report
12/04/22	PRICE SENSITIVE	309.52KB	Share
MEM Follow up sales of FelixTM System
30/03/22	PRICE SENSITIVE	198.06KB	Share
MEM SAMSON stallion fertility device returns positive results
22/03/22		209.49KB	Share
MEM MEM Achieves ISO 13485 Compliance
14/03/22	PRICE SENSITIVE	168.73KB	Share
MEM Presentation at Pitt St Research conference
03/03/22		2.27MB	Share
MEM Appendix 4D and Half Year Report and Accounts
25/02/22	PRICE SENSITIVE	1.08MB	Share
MEM Quarterly Activities/Appendix 4C Cash Flow Report
25/01/22	PRICE SENSITIVE	308.05KB	Share
MEM Change of Director's Interest Notice
24/01/22		172.14KB	Share
MEM Convertible Note sale
19/01/22		149.7KB	Share
MEM First Felix System commercial sale for clinical IVF use
20/12/21	PRICE SENSITIVE	187.71KB	Share
MEM Memphasys & Monash IVF commence clinical trial of FELIX
09/12/21		185.81KB	Share
MEM SAMSON stallion fertility device used in field trials
02/12/21		201.6KB	Share
MEM Change of Director's Interest Notice AC
26/11/21		199.43KB	Share
MEM Results of Meeting
25/11/21		51.47KB	Share
MEM First Sale of FelixTM in Research Application
22/11/21	PRICE SENSITIVE	229.74KB	Share
MEM Verification and Validation Assessments Complete
03/11/21	PRICE SENSITIVE	222.28KB	Share
MEM Notification of cessation of securities - MEM
25/10/21		21.73KB	Share
MEM MEM receives $1.36m R&D tax rebate
25/10/21		169.2KB	Share
MEM Quarterly Activities/Appendix 4C Cash Flow Report
21/10/21	PRICE SENSITIVE	343.4KB	Share
MEM Notice of Annual General Meeting/Proxy Form
19/10/21		480.06KB	Share
MEM Cleansing Notice - Section 708A(5)(e)
28/09/21		206.14KB	Share
MEM Application for quotation of securities - MEM
28/09/21		24.93KB	Share
MEM Acceleration of reproductive biotechnology portfolio
20/09/21		239.76KB	Share
MEM Appendix 3G correction
17/09/21		424.63KB	Share
MEM Notification regarding unquoted securities - MEM
14/09/21		27.81KB	Share
MEM Change of Director's Interest Notice - AC and AG
10/09/21		202.32KB	Share
MEM Appendix 3G
03/09/21		424.59KB	Share
MEM Notification regarding unquoted securities - MEM
01/09/21		28.15KB	Share
MEM MEM reaches settlement agreement with Hydrix
01/09/21	PRICE SENSITIVE	234.86KB	Share
MEM HYD: Commercial arrangement between Hydrix and Memphasys
31/08/21	PRICE SENSITIVE	458.74KB	Share
MEM FY21 Corporate Governance Statement and Appendix 4G
31/08/21		524.12KB	Share
MEM FY21 Full Year Statutory Accounts
30/08/21		1.14MB	Share
MEM Preliminary Final Report
30/08/21	PRICE SENSITIVE	904KB	Share
MEM Results of General Meeting
24/08/21		194.76KB	Share
MEM General Meeting to be held as a Virtual Meeting of members
20/08/21		219.43KB	Share
MEM Disclosure Document - Cleansing Notice
30/07/21		206.28KB	Share
MEM Application for quotation of securities - MEM
30/07/21		24.67KB	Share
MEM Notification regarding unquoted securities - MEM
30/07/21		28.22KB	Share
MEM Quarterly Activities/Appendix 4C Cash Flow Report
26/07/21	PRICE SENSITIVE	300.08KB	Share
MEM Notice of General Meeting/Proxy Form
23/07/21		524.66KB	Share
MEM Global andrology expert, Professor John Aitken, joins MEM
05/07/21		242.01KB	Share
MEM Upgraded Felix Device verification passed
01/07/21		110.65KB	Share
MEM Proposed issue of Securities - MEM
26/05/21		32.45KB	Share
MEM Memphasys completes $3m capital raise
26/05/21	PRICE SENSITIVE	299.47KB	Share
MEM Trading Halt
25/05/21	PRICE SENSITIVE	150.18KB	Share
MEM Assisted reproductive biotechnology products update
04/05/21		274.49KB	Share
MEM Prof. John Aitken receives distinguished andrology award
04/05/21		183.77KB	Share
MEM Quarterly Cashflow Report
30/04/21	PRICE SENSITIVE	162.87KB	Share
MEM Quarterly Activities Report
30/04/21	PRICE SENSITIVE	201.54KB	Share
MEM Granted US patents strengthens IP portfolio
29/04/21		177.95KB	Share
MEM Felix device - V&V progress and KOL study update
27/04/21		197.36KB	Share
MEM FELIX device Verification and Validation process update
30/03/21		205.13KB	Share
MEM Felix device validation testing delayed
08/03/21		180.11KB	Share
MEM Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	1.46MB	Share
MEM Change of Director's Interest Notice - Coutts
17/02/21		139.62KB	Share
MEM Cancellation of Performance Options
17/02/21		132.15KB	Share
MEM Disclosure Document - s708A cleansing notice
02/02/21		206.11KB	Share
MEM Appendix 2A option conversion
02/02/21		290.61KB	Share
MEM Initial Felix product sales update
24/12/20	PRICE SENSITIVE	206.7KB	Share
MEM Executive Chair contract renewal
01/12/20		171.51KB	Share
MEM Results of Meeting
19/11/20		201.6KB	Share
MEM Chairman's Address to Shareholders
19/11/20		250.74KB	Share
MEM FELIX verification and validation update
19/11/20	PRICE SENSITIVE	295.59KB	Share
MEM Reinstatement of Options
28/10/20		172.51KB	Share
MEM Cleansing Statement
19/10/20		221.5KB	Share
MEM Appendix 2A
19/10/20		290.03KB	Share
MEM Notice of Annual General Meeting/Proxy Form
16/10/20		351.69KB	Share
MEM FELIX commercialisation update
09/10/20		216.46KB	Share
MEM MEM receives Good Design Award for Felix device
09/09/20		268.15KB	Share
MEM R&D tax incentive scheme rebate received
09/09/20		136.78KB	Share
MEM 2020 Corporate Governance Statement
07/09/20		286.57KB	Share
MEM 2020 Appendix 4G
07/09/20		152.11KB	Share
MEM Full Year Statutory Accounts
27/08/20		1.13MB	Share
MEM Preliminary Final Report
27/08/20	PRICE SENSITIVE	1.03MB	Share
MEM Disclosure Document - Cleansing Notice
19/08/20		220.79KB	Share
MEM Appendix 2A
19/08/20		289.8KB	Share
MEM MEM and Newcastle Uni prospective reproductive technologies
17/08/20		344.01KB	Share
MEM Performance rights vest on first market entry into Canada
10/07/20		204.78KB	Share
MEM Cancellation of options
06/07/20		152.38KB	Share
MEM Securities Trading Policy
02/07/20		304.55KB	Share
MEM MEM virtual presentation investor webinar
26/06/20		177.77KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change -0.001(11.1%)		Mkt cap ! $7.934M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.4¢	$60.70K	15.16M

Buyers (Bids)

No.	Vol.	Price($)
9	4460257	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	1066202	2

View Market Depth

No.	Vol.	Price($)
9	4460257	0.003
8	5494011	0.002
6	9750024	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	1066202	2
0.005	5087626	10
0.006	5039975	12
0.007	8989817	6
0.008	1782500	5

Last trade - 15.12pm 30/07/2025 (20 minute delay)


Last 0.4¢		Change -0.001 ( 11.1 %)
Open	High	Low	Volume
0.5¢	0.5¢	0.4¢	4996013
Last updated 15.36pm 30/07/2025 ?

MEM (ASX) Chart

MEMPHASYS LIMITED. - Announcements

Corporate Spotlight

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories